Regulation of the Hippo signaling pathway by deubiquitinating enzymes in cancer

Ashley L. Mussell(Roswell Park Comprehensive Cancer Center), Jianmin Zhang(Roswell Park Comprehensive Cancer Center), Costa Frangou(Roswell Park Comprehensive Cancer Center)
Genes & Diseases
June 24, 2019
10.1016/j.gendis.2019.06.004
Cited by 16

Related Papers

VGLL4 Selectively Represses YAP-Dependent Gene Induction and Tumorigenic Phenotypes in Breast Cancer
|Scientific Reports|2017|59
USP1 Regulates TAZ Protein Stability Through Ubiquitin Modifications in Breast Cancer
|Cancers|2020|50
Regulation of local GTP availability controls RAC1 activity and cell invasion
|Nature Communications|2021|44
The Regulatory Role of KIBRA and PTPN14 in Hippo Signaling and Beyond
|Genes|2016|33
NTRK1 is a positive regulator of YAP oncogenic function
|Oncogene|2018|29